The class of 2700089E24Rik inhibitors encompasses a diverse range of compounds that are proposed to modulate the activity of the 2700089E24Rik protein indirectly through their influence on cellular signaling pathways and biochemical processes. These inhibitors are not directly linked to the protein but are thought to affect its function via alterations in related cellular mechanisms. The mechanisms of action of these inhibitors vary widely, reflecting the complexity of cellular signaling networks and the multifaceted nature of protein modulation.
Compounds such as Alsterpaullone and GSK690693, which are inhibitors of cyclin-dependent kinases and AKT respectively, illustrate the approach of targeting key regulatory enzymes in cell signaling pathways. By altering the phosphorylation state of proteins, these inhibitors can influence various cellular processes including cell cycle progression and survival, thereby potentially modulating the function of 2700089E24Rik. Similarly, Torin 1 and AZD8055, as mTOR inhibitors, demonstrate the potential of these compounds to affect protein activity by intervening in pathways critical for cell growth and metabolism.
Additionally, the inhibitor class includes compounds like PD173074 and Sunitinib, which target growth factor receptors and receptor tyrosine kinases. These inhibitors impact signaling pathways that govern cell differentiation, proliferation, and angiogenesis, thus potentially influencing the functional state of 2700089E24Rik. The action of these inhibitors on specific receptors and kinases highlights the indirect approach required to influence proteins not directly associated with these pathways.
In summary, the class of 2700089E24Rik inhibitors represents a diverse group of compounds that are thought to influence the activity of the 2700089E24Rik protein through indirect mechanisms. Their actions are varied but converge on the common objective of modulating cellular processes and signaling pathways that can impact the function of this protein. The diversity of these inhibitors underscores the complexity of cellular signaling and the nuanced approaches required to indirectly influence protein activity.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Alsterpaullone | 237430-03-4 | sc-202453 sc-202453A | 1 mg 5 mg | $68.00 $312.00 | 2 | |
A cyclin-dependent kinase inhibitor, potentially altering protein phosphorylation and signaling pathways. | ||||||
Torin 1 | 1222998-36-8 | sc-396760 | 10 mg | $245.00 | 7 | |
An mTOR inhibitor, known to affect cell growth and survival pathways, potentially impacting protein activity. | ||||||
Gö 6983 | 133053-19-7 | sc-203432 sc-203432A sc-203432B | 1 mg 5 mg 10 mg | $105.00 $299.00 $474.00 | 15 | |
A protein kinase C inhibitor, which can affect signaling pathways related to cell proliferation and survival. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
An Src family kinase inhibitor, potentially influencing cellular communication and protein interactions. | ||||||
PD173074 | 219580-11-7 | sc-202610 sc-202610A sc-202610B | 1 mg 5 mg 50 mg | $47.00 $143.00 $680.00 | 16 | |
A fibroblast growth factor receptor inhibitor, impacting cell growth and differentiation pathways. | ||||||
GSK 690693 | 937174-76-0 | sc-363280 sc-363280A | 10 mg 50 mg | $255.00 $1071.00 | 4 | |
An AKT inhibitor, affecting signaling pathways related to cell survival and metabolism. | ||||||
Sunitinib, Free Base | 557795-19-4 | sc-396319 sc-396319A | 500 mg 5 g | $153.00 $938.00 | 5 | |
A receptor tyrosine kinase inhibitor, potentially impacting various signaling pathways including VEGF and PDGF receptors. | ||||||
Lapatinib | 231277-92-2 | sc-353658 | 100 mg | $420.00 | 32 | |
A dual inhibitor of EGFR and HER2, known to affect cell signaling related to growth and survival. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
A kinase inhibitor with activity against RAF, VEGFR, and PDGFR, potentially impacting cell growth and angiogenesis. | ||||||
Vemurafenib | 918504-65-1 | sc-364643 sc-364643A | 10 mg 50 mg | $117.00 $423.00 | 11 | |
A BRAF inhibitor, affecting the MAPK/ERK signaling pathway, which is crucial for cell proliferation and survival. | ||||||